OTHER SHOWS

Conference Programme

Loading

Groundbreaking New OA Treatment That Breaks the Inflammatory Cycle

Apr 20, 2020
Innovation Showcase
Orthopedics

The management of the chronic pain and inflammation of canine osteoarthritis is a common and significant challenge for practitioners.  Come learn about an exciting new transformational treatment that uses the novel radioisotope tin 117m (Synovetin OA™) to safely target the source of inflammation for long-lasting results

  • Participants will learn:
  • The role of synovitis in OA, the science behind the micro-environment of the joint and synovium as a target for therapeutic intervention and long term results.
  • The attributes and mechanism of action of the highly innovative radioisotope tin 117m, and the long history of safe use of radioisotopes to treat arthritis in people.
  • The outstanding efficacy, safety, and overall treatment experience using Synovetin OA from a lead clinical investigator.
Speakers
Michelle Fabiani, Director of Interventional Radiology - Gulf Coast Veterinary Specialists
Nigel Stevenson, Chief Commercial Officer/President - Exubrion Therapeutics/World Council on Isotopes
Steven M. Fox, Senior Veterinarian - Exubrion Therapeutics